Evidence map›Paper›PMID 35462566›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

[

Rong Lin, Zefang Lin, Zhenying Chen, Shan Zheng, Jiaying Zhang, Jie Zang, Weibing Miao

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05420558 (The Application of Molecular Probe Targeting Fibroblast Activation Protein in Malignant Tumor of Digestive System), which is not on this map. Cited by 57 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 7 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05420558 unknown statusnot on this map

The Application of Molecular Probe Targeting Fibroblast Activation Protein in Malignant Tumor of Digestive System

TypeobservationalSponsorZhongnan HospitalRan2022 to 2023Enrolled100ConditionsGastrointestinal CancerArmsFibroblast activation protein inhibitor PET/CT imaging
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 7 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Diagnostic performance of [Frontiers in medicine · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. [European journal of medical research · 2023
    Pooled it
  5. Comparison ofFrontiers in oncology · 2023
    Pooled it
  6. Head-to-head comparison ofFrontiers in oncology · 2023
    Pooled it
  7. Pooled it
  8. The role of [European journal of nuclear medicine and molecular imaging · 2023
    Trial
  9. Association of Atherosclerosis [Molecular imaging and biology · 2026
    Article
  10. Diagnostic value of [Abdominal radiology (New York) · 2026
    Article
  11. Article
  12. Superiority of [Annals of surgical oncology · 2026
    Article
  13. [Scientific reports · 2026
    Article
  14. Review
  15. Article
  16. [Abdominal radiology (New York) · 2026
    Article
  17. Review
  18. First-in-human study of a novel bifunctional PET tracer [European journal of nuclear medicine and molecular imaging · 2026
    Article
  19. Diagnostic Efficacy of FAPI-PET/CT Versus [Diagnostics (Basel, Switzerland) · 2026
    Review
  20. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rong LinDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Zefang LinDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Zhenying ChenDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Shan ZhengDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Jiaying ZhangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China.
Jie ZangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China. 15901495106@163.com.
Weibing MiaoDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou, 350005, Fujian Province, China. miaoweibing@126.com.ORCID 0000-0002-0058-4953
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to compare the performance of [

methodsFifty-six patients with histologically proven gastric carcinomas were enrolled in this study, including 45 patients for staging and 11 patients for restaging after surgery. Each patient underwent both [

results[

conclusions[

Indexed as

Fluorodeoxyglucose F18Stomach NeoplasmsGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansLymphatic MetastasisPositron Emission Tomography Computed TomographyQuinolines1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesHeterocyclic Compounds, 1-RingQuinolines[18F]FDG PET/CT[68Ga]Ga-DOTA-FAPI-04Gastric cancerLymph node metastasis

Identifiers

PMID35462566
OpenAlexW4224322758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.